Regulatory communication and documentation compliance remain persistent challenges in clinical development. Global regulatory affairs provides a structured approach to addressing these demands. It connects development decisions, compliant documentation, and engagement with health authorities across markets, supporting the product throughout its life cycle—from clinical development through marketing authorization to postmarketing safety monitoring.

What Is Regulatory Affairs Consulting?

Regulatory affairs consulting provides scientific, regulatory, and operational guidance for the development, authorization, and lifecycle management of medicines and other regulated medical products. It helps sponsors interpret applicable laws, agency guidance, and submission requirements, then translate product evidence and development plans into a structured regulatory pathway.

In clinical development, global regulatory affairs serves as a cross-functional discipline. It links nonclinical research, clinical operations, biostatistics, pharmacovigilance, and chemistry, manufacturing, and controls (CMC). This coordination helps ensure that clinical trial documents, safety information, manufacturing data, and regulatory submissions are accurate, consistent, and suitable for the intended market.

The role extends beyond obtaining an initial authorization. Regulatory professionals can support authority interactions, submission maintenance, post-approval changes, pharmacovigilance activities, and ongoing compliance throughout the product life cycle. This lifecycle perspective is particularly relevant in global development, where regulatory systems are increasingly aligned through international standards but continue to differ in legal requirements, local procedures, and evidence expectations.

What Services Does Global Regulatory Affairs Typically Include?

The scope of global regulatory affairs services varies by product type, development stage, and target market. In drug clinical development and registration, these services commonly include:

· Regulatory Strategy and Intelligence Support: Assessing the regulatory landscape and potential gaps in target markets; developing a global regulatory strategy, market entry sequence, and health authority communication plan; and monitoring relevant regulations, guidance, and regulatory practices.

· Clinical Trial Regulatory Support: Preparing and managing INDs, CTAs, and other clinical trial applications; reviewing core documents such as clinical trial protocols, Investigator’s Brochures, and informed consent forms; and supporting amendments and trial closeout-related activities.

· Marketing Authorization Submission Support: Assisting with the preparation and management of NDAs, BLAs, MAAs, and other applicable registration submissions, as well as coordinating supplementary information and review questions during the submission process.

· Health Authority Communication Support: Preparing meeting requests, briefing packages, and formal response documents; and coordinating health authority inquiries, requests for additional information, and related communication records.

· Post-Approval Regulatory Maintenance Support: Supporting coordination related to post-approval changes, submission maintenance, and other ongoing regulatory activities.

The Roles and Responsibilities of Regulatory Affairs Professionals

Regulatory affairs consultants and professionals guide the complex journey of a drug from preclinical research to market, managing rigorous testing, ensuring adherence to global standards, and supporting ongoing compliance and monitoring after approval.

Their responsibilities not only help uphold industry integrity but also contribute to the protection of public health.

Explore more about CRO services: What Are CRO Services and How to Choose the Right CRO Company?

Knowledge Card

Key Clinical Research Regulatory Agencies

Each agency maintains distinct legal frameworks, submission procedures, data expectations, and communication processes. A global regulatory strategy for pharmaceuticals requires sponsors to assess these differences early and plan regulatory activities accordingly.

Key Regulatory Pathways and Submission 

Common Regulatory Challenges in Global Development and How a CRO Partner Can Help

Challenge 1: Inconsistent Documentation Across Jurisdictions

When sponsors file in multiple markets simultaneously, formatting standards, required datasets, and supporting documentation can vary significantly. A dossier accepted by the FDA may need restructuring for EMA or NMPA review, and gaps in regional requirements often surface late, leading to rejections or delays.

How a CRO partner can help:

· Conduct early-stage gap analyses through regulatory submission consulting to identify documentation shortfalls before they become obstacles.

· Map each region's specific requirements at the outset, building a unified dossier framework for global regulatory submission.

· Apply life science regulatory intelligence & strategy to reduce redundant work and align multi-region filings.

Challenge 2: Managing Regulatory Agency Communication

The format, timing, and content of pre-submission meetings, scientific advice requests, and formal responses differ across agencies. Missteps in agency communication can lead to misaligned expectations, additional data requests, or review delays.

How a CRO partner can help:

· Prepare briefing documents and structure responses in each agency's expected format, drawing on clinical trial regulatory services expertise.

· Guide sponsors through FDA regulatory affairs consulting protocols, including pre-IND and pre-NDA meeting preparation.

· Coordinate EMA regulatory affairs interactions with the Rapporteur and member state reviewers.

· Anticipate agency questions and help sponsors present a clear, well-organized case.

Challenge 3: Navigating Expedited Regulatory Pathways

Expedited programs such as BTD, PRIME, and Conditional Approval offer potential timeline advantages, but eligibility criteria, supporting evidence thresholds, and post-designation commitments vary by program and agency.

How a CRO partner can help:

· Evaluate a sponsor's data package against each program's criteria.

· Prepare designation requests aligned with agency expectations.

· Provide regulatory affairs services support to help sponsors decide which expedited pathways to pursue and how to structure their submissions.

Tigermed Global Regulatory Affairs Services

Tigermed provides regulatory affairs consulting covering IND and NDA submissions, regulatory strategy development, agency communication, gap analysis, DMF/CEP registration, and lifecycle management. The scope of Tigermed's services extends to both small molecules and biologics, including multi-regional clinical trial (MRCT) regulatory coordination. With nearly 60 regulatory professionals experienced across NMPA, FDA, and EMA submissions, Tigermed has supported over 4,200 drug registration projects for more than 1,000 clients globally.

Tigermed's global regulatory affairs services are designed to help sponsors plan and execute regulatory submissions with clarity across therapeutic areas and development phases. To learn more about how Tigermed can support your regulatory needs, please feel free to contact our team.

Conclusion

Global regulatory affairs determines how clinical evidence is documented, reviewed, and accepted across jurisdictions. For sponsors operating in multiple markets, the quality of regulatory planning directly affects submission outcomes, review timelines, and time to market access. With global regulatory affairs capabilities and extensive registration experience, Tigermed is committed to helping sponsors address complex regulatory requirements and accelerate the journey of innovative products from development to market access.

* Disclaimer: This article is compiled from publicly available information and is intended to provide a general overview of global regulatory affairs concepts, processes, and related services in clinical development. It is provided for general reference only and does not constitute regulatory, legal, medical, or professional advice.